{"slideshow_credits": null, "snippet": "For each of the past three years, opioid prescriptions have declined in the United States, the first sustained drop since OxyContin hit the market in 1996.", "abstract": "Opioid prescriptions in United States have fallen in each of past three years, first sustained drop  since OxyContin entered market in 1996; experts attribute drop to federal and state initiatives to monitor prescription drug use.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Abby", "role": "reported", "lastname": "GOODNOUGH", "rank": 1, "organization": ""}, {"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 2, "organization": ""}], "original": "By ABBY GOODNOUGH and SABRINA TAVERNISE"}, "web_url": "http://www.nytimes.com/2016/05/21/health/opioid-prescriptions-drop-for-first-time-in-two-decades.html", "lead_paragraph": "For each of the past three years, opioid prescriptions have declined in the United States, the first sustained drop since OxyContin hit the market in 1996.", "headline": {"main": "Opioid Prescriptions Drop for First Time in Two Decades", "print_headline": "Prescription Dip Seen as Advance in Opioid Battle"}, "_id": "573f6c2438f0d85766bbeb2a", "word_count": "1367", "multimedia": [{"height": 126, "url": "images/2016/05/21/science/21PRESCRIBE/21PRESCRIBE-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/05/21/science/21PRESCRIBE/21PRESCRIBE-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2016/05/21/science/21PRESCRIBE/21PRESCRIBE-articleLarge.jpg", "legacy": {"xlarge": "images/2016/05/21/science/21PRESCRIBE/21PRESCRIBE-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/05/21/science/21PRESCRIBE/21PRESCRIBE-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/05/21/science/21PRESCRIBE/21PRESCRIBE-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-05-21T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Pain-Relieving Drugs", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drug Abuse and Traffic", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "OxyContin (Drug)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "IMS Health", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Addiction (Psychology)", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}